- JAZZ has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $82.2 million.
- JAZZ is down 2.8% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in JAZZ with the Ticky from Trade-Ideas. See the FREE profile for JAZZ NOW at Trade-Ideas More details on JAZZ: Jazz Pharmaceuticals Public Limited Company, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various medical needs in the United States, Europe, and internationally. JAZZ has a PE ratio of 189.7. Currently there are 10 analysts that rate Jazz Pharmaceuticals a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Jazz Pharmaceuticals has been 693,300 shares per day over the past 30 days. Jazz has a market cap of $10.8 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.83 and a short float of 5.1% with 6.46 days to cover. Shares are up 7.8% year-to-date as of the close of trading on Wednesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.